Breaking News Instant updates and real-time market news.

CLB

Core Laboratories

$37.10 /

-10.24 (-21.63%)

12:00
12/31/19
12/31
12:00
12/31/19
12:00

Core Laboratories falls -21.9%

Core Laboratories is down -21.9%, or -$10.41 to $37.05.

  • 30

    Jan

  • 23

    Mar

CLB Core Laboratories
$37.10 /

-10.24 (-21.63%)

12/31/19 Cowen
Core Laboratories price target lowered to $39 from $42 at Cowen
12/31/19 JPMorgan
Core Laboratories price target lowered to $47 from $50 at JPMorgan
10/17/19 ABN Amro
Core Laboratories downgraded to Hold from Buy at ABN Amro
07/10/19
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Upgrade
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70 » 07:54
09/21/20
09/21
07:54
09/21/20
07:54
ACB

Aurora Cannabis

$6.54 /

-0.35 (-5.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

05:20 Today Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
09/09/20 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$17.50 from C$29 at Cantor Fitzgerald
09/08/20 Ladenburg
Aurora Cannabis downgraded to Neutral at Ladenburg on slower progress
ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

Recommendations
Amedisys price target raised to $260 from $250 at Oppenheimer » 07:51
09/21/20
09/21
07:51
09/21/20
07:51
AMED

Amedisys

$233.73 /

-1.39 (-0.59%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$233.73 /

-1.39 (-0.59%)

AMED Amedisys
$233.73 /

-1.39 (-0.59%)

09/10/20 Stephens
Amedisys price target raised to $245 from $235 at Stephens
09/02/20 BMO Capital
Amedisys price target raised to $270 from $250 at BMO Capital
07/30/20 Deutsche Bank
Amedisys price target raised to $260 from $220 at Deutsche Bank
07/30/20 Raymond James
Amedisys price target raised to $255 from $210 at Raymond James
AMED Amedisys
$233.73 /

-1.39 (-0.59%)

General news
Treasury Market Outlook: there's a big risk-off trade in the market » 07:50
09/21/20
09/21
07:50
09/21/20
07:50

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Stephens says Darden still a top pick, expects in-line Q1 comps » 07:49
09/21/20
09/21
07:49
09/21/20
07:49
DRI

Darden

$89.98 /

-1.62 (-1.77%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

06:42 Today RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
06:40 Today Wedbush
Darden downgraded to Neutral from Outperform at Wedbush on valuation
06:34 Today Wedbush
Darden downgraded to Neutral from Outperform at Wedbush
09/18/20 MKM Partners
Darden price target raised to $110 from $90 at MKM Partners
DRI Darden
$89.98 /

-1.62 (-1.77%)

  • 21
    Apr
DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

Conference/Events
Axsome Therapeutics to host conference call » 07:45
09/21/20
09/21
07:45
09/21/20
07:45
AXSM

Axsome Therapeutics

$81.70 /

+2.44 (+3.08%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

09/10/20 Morgan Stanley
Axsome Therapeutics initiated with an Overweight at Morgan Stanley
09/01/20 Guggenheim
Axsome's Alzheimer's agitation update better than expected, says Guggenheim
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

  • 19
    Dec
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

Hot Stocks
Adicet Bio down 13% to $18.61 after announcing 4.5M secondary offering  07:44
09/21/20
09/21
07:44
09/21/20
07:44
ACET

Adicet Bio

$18.48 /

+2.29 (+14.14%)

 
ShowHide Related Items >><<
ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

Recommendations
Coupa Software price target raised to $330 from $272 at Morgan Stanley » 07:42
09/21/20
09/21
07:42
09/21/20
07:42
COUP

Coupa Software

$248.03 /

+3.54 (+1.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

09/14/20 Citi
Coupa Software price target lowered to $275 from $313 at Citi
09/09/20 FBN Securities
Coupa Software price target raised to $300 from $255 at FBN Securities
09/09/20 RBC Capital
Coupa Software price target raised to $300 from $245 at RBC Capital
09/09/20 Needham
Coupa Software price target raised to $300 from $255 at Needham
COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

Syndicate
Adicet Bio files to sell 4.5M shares of common stock » 07:40
09/21/20
09/21
07:40
09/21/20
07:40
ACET

Adicet Bio

$18.48 /

+2.29 (+14.14%)

BofA Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

Earnings
Theratechnologies sees Q3 revenue $13.8M-$14.2M vs. 16.1M last year » 07:39
09/21/20
09/21
07:39
09/21/20
07:39
THTX

Theratechnologies

$2.60 /

+0.12 (+4.84%)

Revenues for the third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

Hot Stocks
Legacy Acquisition to acquire Onyx Enterprises for $20M in cash, $265M in shares » 07:38
09/21/20
09/21
07:38
09/21/20
07:38
LGC

Legacy Acquisition Corp

$10.50 /

+ (+0.00%)

Legacy Acquisition Corp…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGC Legacy Acquisition Corp
$10.50 /

+ (+0.00%)

Hot Stocks
Savaria appoints Stephen Reitknecht as CFO » 07:38
09/21/20
09/21
07:38
09/21/20
07:38
SISXF

Savaria

$0.00 /

+ (+0.00%)

Savaria Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SISXF Savaria
$0.00 /

+ (+0.00%)

08/17/20
Fly Intel: Top five analyst initiations
08/17/20 TD Securities
Savaria initiated with a Hold at TD Securities
08/14/20 Stifel
Savaria price target raised to C$18 from C$16.50 at Stifel
08/14/20 Scotiabank
Savaria price target raised to C$18 from C$16 at Scotiabank
Hot Stocks
BridgeBio's Calcilytix initiates Phase 2 study of encaleret for ADH1 » 07:37
09/21/20
09/21
07:37
09/21/20
07:37
BBIO

BridgeBio

$42.22 /

+3.8 (+9.89%)

BridgeBio Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

08/17/20 H.C. Wainwright
BridgeBio portfolio company granted orphan status, says H.C. Wainwright
06/25/20 BofA
BridgeBio initiated with a Neutral at BofA
06/25/20 BofA
BridgeBio initiated with a Neutral at BofA
06/05/20 Mizuho
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho
BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

  • 29
    May
Hot Stocks
MacroGenics announces $15M milestone triggered under Incyte agreement » 07:35
09/21/20
09/21
07:35
09/21/20
07:35
MGNX

MacroGenics

$31.61 /

+0.33 (+1.05%)

, INCY

Incyte

$86.83 /

-3.5 (-3.87%)

MacroGenics (MGNX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

08/03/20 Citi
MacroGenics downgraded to Neutral from Buy at Citi
06/02/20 Citi
MacroGenics price target raised to $25 from $15 at Citi
06/01/20 Guggenheim
Guggenheim upgrades MacroGenics to Buy on pipeline prospects
06/01/20 Guggenheim
MacroGenics upgraded to Buy from Neutral at Guggenheim
INCY Incyte
$86.83 /

-3.5 (-3.87%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

Initiation
CorMedix started with a Buy at Truist on Defencath potential » 07:35
09/21/20
09/21
07:35
09/21/20
07:35
CRMD

CorMedix

$4.60 /

-0.09 (-1.92%)

Truist analyst Joon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRMD CorMedix
$4.60 /

-0.09 (-1.92%)

CRMD CorMedix
$4.60 /

-0.09 (-1.92%)

06:22 Today Truist
CorMedix initiated with a Buy at Truist
12/18/19 B. Riley FBR
B. Riley FBR starts CorMedix with Buy rating, $15 price target
12/18/19 B. Riley FBR
CorMedix initiated with a Buy at B. Riley FBR
  • 28
    Jul
CRMD CorMedix
$4.60 /

-0.09 (-1.92%)

Options
Unusual call flow in option market yesterday » 07:35
09/21/20
09/21
07:35
09/21/20
07:35
VALE

Vale

$11.51 /

-0.375 (-3.16%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VALE Vale
$11.51 /

-0.375 (-3.16%)

VALE Vale
$11.51 /

-0.375 (-3.16%)

06/11/20 Deutsche Bank
Vale price target raised to $13 from $11 at Deutsche Bank
06/09/20 GLJ Research
Fortescue Metals upgraded to Hold from Sell at GLJ Research
06/05/20 Exane BNP Paribas
Vale upgraded to Outperform from Neutral at Exane BNP Paribas
06/03/20 UBS
Vale upgraded to Buy from Neutral at UBS
VALE Vale
$11.51 /

-0.375 (-3.16%)

VALE Vale
$11.51 /

-0.375 (-3.16%)

Hot Stocks
TC Energy president, CEO Russ Girling to retire, Francois Poirier to succeed » 07:33
09/21/20
09/21
07:33
09/21/20
07:33
TRP

TC Energy

$45.84 /

+0.28 (+0.61%)

TC Energy announced Russ…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$45.84 /

+0.28 (+0.61%)

TRP TC Energy
$45.84 /

+0.28 (+0.61%)

08/06/20 BMO Capital
TC Energy price target raised to C$68 from C$65 at BMO Capital
07/15/20 Scotiabank
TC Energy upgraded to Outperform on recent selloff at Scotiabank
07/15/20 Scotiabank
TC Energy upgraded to Outperform from Sector Perform at Scotiabank
07/10/20 US Capital Advisors
TC Energy initiated with a Buy at US Capital Advisors
TRP TC Energy
$45.84 /

+0.28 (+0.61%)

Hot Stocks
Crinetics receives rare pediatric disease designation for CRN04777 » 07:32
09/21/20
09/21
07:32
09/21/20
07:32
CRNX

Crinetics

$15.81 /

-0.24 (-1.50%)

Crinetics Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNX Crinetics
$15.81 /

-0.24 (-1.50%)

CRNX Crinetics
$15.81 /

-0.24 (-1.50%)

08/07/20 Piper Sandler
Crinetics likely to report positive Phase 2 results in Q4, says Piper Sandler
05/11/20 Cantor Fitzgerald
Crinetics price target raised to $38 from $28 at Cantor Fitzgerald
05/08/20 Piper Sandler
Piper Sandler continues to recommend Crinetics after paltusotine data
04/07/20 Piper Sandler
Crinetics shares 'should be up meaningfully,' says Piper Sandler
CRNX Crinetics
$15.81 /

-0.24 (-1.50%)

  • 15
    Apr
CRNX Crinetics
$15.81 /

-0.24 (-1.50%)

Hot Stocks
Jones Lang LaSalle commits to achieving net zero carbon emissions by 2030 » 07:31
09/21/20
09/21
07:31
09/21/20
07:31
JLL

Jones Lang LaSalle

$103.13 /

-3.03 (-2.85%)

JLL is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$103.13 /

-3.03 (-2.85%)

JLL Jones Lang LaSalle
$103.13 /

-3.03 (-2.85%)

04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
02/11/20 Keefe Bruyette
Jones Lang LaSalle selloff on Q4 results overdone, says Keefe Bruyette
11/26/19 BofA/Merrill
Jones Lang LaSalle initiated with a Neutral at BofA/Merrill
JLL Jones Lang LaSalle
$103.13 /

-3.03 (-2.85%)

Upgrade
ManpowerGroup upgraded to Buy from Hold at Truist » 07:26
09/21/20
09/21
07:26
09/21/20
07:26
MAN

ManpowerGroup

$70.72 /

+0.19 (+0.27%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAN ManpowerGroup
$70.72 /

+0.19 (+0.27%)

06:33 Today Truist
ManpowerGroup upgraded to Buy from Hold at Truist
07/21/20 CL King
ManpowerGroup estimates lowered on macro uncertainty at CL King
07/16/20 RBC Capital
ManpowerGroup price target raised to $95 from $90 at RBC Capital
07/14/20
Fly Intel: Top five analyst downgrades
MAN ManpowerGroup
$70.72 /

+0.19 (+0.27%)

MAN ManpowerGroup
$70.72 /

+0.19 (+0.27%)

Conference/Events
Benchmark tech analyst to hold an analyst/industry conference call » 07:25
09/21/20
09/21
07:25
09/21/20
07:25

Technology Analyst Jiang,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Open Lending data provides attractive setup exiting Q3, says Canaccord » 07:23
09/21/20
09/21
07:23
09/21/20
07:23
LPRO

Open Lending

$21.90 /

+0.14 (+0.64%)

Canaccord analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPRO Open Lending
$21.90 /

+0.14 (+0.64%)

LPRO Open Lending
$21.90 /

+0.14 (+0.64%)

08/12/20 Canaccord
Open Lending price target raised to $25 from $20 at Canaccord
07/24/20
Fly Intel: Top five analyst initiations
07/24/20 Deutsche Bank
Deutsche Bank starts Open Lending with Buy, $23 price target
07/23/20 Deutsche Bank
Open Lending initiated with a Buy at Deutsche Bank
LPRO Open Lending
$21.90 /

+0.14 (+0.64%)

LPRO Open Lending
$21.90 /

+0.14 (+0.64%)

Hot Stocks
Northern Oil and Gas completes 1-for-10 reverse split, provides outlook » 07:22
09/21/20
09/21
07:22
09/21/20
07:22
NOG

Northern Oil and Gas

$56.85 /

+1.3 (+2.34%)

Northern completed the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOG Northern Oil and Gas
$56.85 /

+1.3 (+2.34%)

NOG Northern Oil and Gas
$56.85 /

+1.3 (+2.34%)

08/27/20 Roth Capital
Northern Oil and Gas initiated with a Buy at Roth Capital
07/27/20 Seaport Global
Northern Oil and Gas initiated with a Buy at Seaport Global
07/01/20 SunTrust
Northern Oil and Gas upgraded to Buy from Hold at SunTrust
07/01/20 SunTrust
Northern Oil and Gas upgraded to Buy from Hold at SunTrust
NOG Northern Oil and Gas
$56.85 /

+1.3 (+2.34%)

NOG Northern Oil and Gas
$56.85 /

+1.3 (+2.34%)

Periodicals
Boeing nears decision to shift more 787 production to SC, Reuters reports » 07:21
09/21/20
09/21
07:21
09/21/20
07:21
BA

Boeing

$161.07 /

-6.46 (-3.86%)

Boeing is nearing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$161.07 /

-6.46 (-3.86%)

BA Boeing
$161.07 /

-6.46 (-3.86%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Boeing upgraded to Conviction Buy from Buy at Goldman Sachs
09/10/20 Susquehanna
Boeing 737 MAX making progress, but estimates lowered at Susquehanna
09/09/20 Canaccord
Boeing downside risk to production plans seen, says Canaccord
BA Boeing
$161.07 /

-6.46 (-3.86%)

BA Boeing
$161.07 /

-6.46 (-3.86%)

BA Boeing
$161.07 /

-6.46 (-3.86%)

BA Boeing
$161.07 /

-6.46 (-3.86%)

Hot Stocks
IIP acquires Florida property, expands real estate partnership with Parallel » 07:20
09/21/20
09/21
07:20
09/21/20
07:20
IIPR

Innovative Industrial Properties

$124.80 /

-1.21 (-0.96%)

Innovative Industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IIPR Innovative Industrial Properties
$124.80 /

-1.21 (-0.96%)

IIPR Innovative Industrial Properties
$124.80 /

-1.21 (-0.96%)

09/18/20 Roth Capital
Innovative Industrial Properties price target raised to $150 from $125 at Roth Capital
09/17/20 BTIG
Innovative Industrial Properties price target raised to $177 from $151 at BTIG
09/08/20 Piper Sandler
Innovative Industrial Properties initiated with an Overweight at Piper Sandler
08/17/20 JMP Securities
Innovative Industrial Properties price target raised to $140 from $120 at JMP Securities
IIPR Innovative Industrial Properties
$124.80 /

-1.21 (-0.96%)

  • 30
    Jun
  • 27
    May
  • 24
    Jan
IIPR Innovative Industrial Properties
$124.80 /

-1.21 (-0.96%)

Recommendations
Seres Therapeutics price target raised to $42 from $38 at Canaccord » 07:20
09/21/20
09/21
07:20
09/21/20
07:20
MCRB

Seres Therapeutics

$25.63 /

-1.23 (-4.58%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$25.63 /

-1.23 (-4.58%)

MCRB Seres Therapeutics
$25.63 /

-1.23 (-4.58%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
08/18/20
Fly Intel: Top five analyst initiations
08/18/20 Piper Sandler
Seres Therapeutics initiated with an Overweight at Piper Sandler
08/11/20 H.C. Wainwright
Seres Therapeutics price target raised to $41 from $8 at H.C. Wainwright
MCRB Seres Therapeutics
$25.63 /

-1.23 (-4.58%)

  • 13
    Aug
MCRB Seres Therapeutics
$25.63 /

-1.23 (-4.58%)

MCRB Seres Therapeutics
$25.63 /

-1.23 (-4.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.